Gene · 2646
Papers2,346
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,346
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Metabolic phenotyping of patients with advanced chronic liver disease for better characterization of cirrhosis regression. | J Hepatol | 2024 | 38944391 | PubTator, text mining | PubMed |
| Turning Points in Cross-Disciplinary Perspective of Primary Hyperparathyroidism and Pancreas Involvements: Hypercalcemia-Induced Pancreatitis, MEN1 Gene-Related Tumors, and Insulin Resistance. | Int J Mol Sci | 2024 | 38928056 | PubTator, text mining | PubMed |
| Interplay of Mediterranean-diet adherence, genetic factors, and metabolic dysfunction-associated steatotic liver disease risk in Korea. | J Transl Med | 2024 | 38918799 | PubTator, text mining | PubMed |
| Dengue Virus dependence on glucokinase activity and glycolysis Confers Sensitivity to NAD(H) biosynthesis inhibitors. | Antiviral Res | 2024 | 38909960 | PubTator, text mining | PubMed |
| Identification of novel therapeutic targets for chronic kidney disease and kidney function by integrating multi-omics proteome with transcriptome. | Genome Med | 2024 | 38898508 | PubTator, text mining | PubMed |
| GlycA and CRP Are Genetically Correlated: Insight into the Genetic Architecture of Inflammageing. | Biomolecules | 2024 | 38785970 | PubTator, text mining | PubMed |
| Proteome-wide Mendelian randomization identifies potential therapeutic targets for nonalcoholic fatty liver diseases. | Sci Rep | 2024 | 38782984 | PubTator, text mining | PubMed |
| Glucokinase regulatory protein rs780094 polymorphism is associated with type 2 diabetes mellitus, dyslipidemia, non-alcoholic fatty liver disease, and nephropathy. | World J Diabetes | 2024 | 38766433 | PubTator, text mining | PubMed |
| Association of GCKR and MBOAT7 genetic polymorphisms with non-alcoholic fatty liver disease. | Clin Exp Hepatol | 2024 | 38765903 | PubTator, text mining | PubMed |
| Sex-Dimorphic Effects of Hypoglycemia on Metabolic Sensor mRNA Expression in Ventromedial Hypothalamic Nucleus-Dorsomedial Division (VMNdm) Growth Hormone-Releasing Hormone Neurons. | ACS Chem Neurosci | 2024 | 38757688 | PubTator, text mining | PubMed |
| Unravelling genetic architecture of circulatory amino acid levels, and their effect on risk of complex disorders. | NAR Genom Bioinform | 2024 | 38711861 | PubTator, text mining | PubMed |
| Relevance of PNPLA3, TM6SF2, HSD17B13, and GCKR Variants to MASLD Severity in an Egyptian Population. | Genes (Basel) | 2024 | 38674389 | PubTator, text mining | PubMed |
| Obesity-Dependent Association of the rs10454142 PPP1R21 with Breast Cancer. | Biomedicines | 2024 | 38672173 | PubTator, text mining | PubMed |
| Molecular Genealogy of Metabolic-associated Hepatocellular Carcinoma. | Semin Liver Dis | 2024 | 38499207 | PubTator, text mining | PubMed |
| The pleiotropic approach to coronavirus disease-19 pathogenesis: The impact of liver diseases associated host genetic variants. | Hepatol Forum | 2024 | 38487739 | PubTator, text mining | PubMed |
| Altered lipid metabolism and the development of metabolic-associated fatty liver disease. | Curr Opin Lipidol | 2024 | 38484227 | PubTator, text mining | PubMed |
| PARVB and HSD17B13 variants are associated with nonalcoholic fatty liver disease in children. | J Gastroenterol Hepatol | 2024 | 38418429 | PubTator, text mining | PubMed |
| Sex-Hormone-Binding Globulin Gene Polymorphisms and Breast Cancer Risk in Caucasian Women of Russia. | Int J Mol Sci | 2024 | 38396861 | PubTator, text mining | PubMed |
| Metabolomic and genetic architecture of gestational diabetes subtypes. | Diabetologia | 2024 | 38367033 | PubTator, text mining | PubMed |
| Liver Biopsy Handling of Metabolic-Associated Fatty Liver Disease (MAFLD): the Children's Hospital of Eastern Ontario grossing protocol. | Ther Adv Endocrinol Metab | 2024 | 38322111 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2646/papers?page=8